Director, Financial Planning and Analysis, Commercial

Company Overview:

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Position Overview: 

The Director, Financial Planning and Analysis, Commercial, will be a key member of the FP&A team reporting to the VP of FP&A. The focus of this position will be managing the planning processes and serving as the business partner to the Commercial organization and working cross-functionally to ensure accuracy of commercial revenue projections. This position will also be responsible for most financial modeling projects on the FP&A team and interact closely with the accounting team on the month end closing process.

Responsibilities 

• FP&A business partner to the Commercial, and risto-cel program.
• Oversee planning cycle activities and review and ensure accuracy of plan data for all partner functions and programs.
• Conduct monthly budget vs. actual analysis for partner functions and programs and finance/management results.
• Track risks and opportunities to the annual budget and enter material changes into rolling forecast.
• Assist in the overall budget, LRP, and forecast processes outside of partnership duties.
• Partner with Commercial and Manufacturing to assess risto-cel commercial patient forecasts and pressure test assumptions and outputs.  
• Partner with Accounting and Commercial to assess risto-cel commercial revenue forecasts and pressure test assumptions and outputs.
• Partner with Commercial to assess patient and revenue forecasts and pressure test assumptions for additional commercial launches and pipeline commercial opportunities.
• Build and maintain complex, integrated financial models supporting long-range planning, valuation, and strategic decision-making to assess key business risks and opportunities.
• Special projects as required. 

Requirements 

• 8+ years of overall FP&A experience (2+ year commercial FP&A experience); biotech industry experience strongly preferred.